Cardiovascular risk of electronic cigarettes: a review of preclinical and clinical studies.
Aldehydes
/ adverse effects
Animals
Cardiovascular Diseases
/ diagnosis
Cardiovascular System
/ drug effects
Consumer Product Safety
E-Cigarette Vapor
/ adverse effects
Electronic Nicotine Delivery Systems
Flavoring Agents
/ adverse effects
Humans
Metals
/ adverse effects
Nicotine
/ adverse effects
Oxidants
/ adverse effects
Risk Assessment
Risk Factors
Vaping
/ adverse effects
Aerosol
Cardiovascular disease
Electronic cigarette
Nicotine
Smoking
Toxicity
Journal
Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427
Informations de publication
Date de publication:
01 01 2020
01 01 2020
Historique:
received:
05
04
2019
revised:
08
08
2019
accepted:
04
10
2019
pubmed:
7
11
2019
medline:
26
8
2020
entrez:
8
11
2019
Statut:
ppublish
Résumé
Cigarette smoking is the most preventable risk factor related to cardiovascular morbidity and mortality. Tobacco usage has declined in recent years; however, the use of alternative nicotine delivery methods, particularly e-cigarettes, has increased exponentially despite limited data on their short- and long-term safety and efficacy. Due to their unique properties, the impact of e-cigarettes on cardiovascular physiology is not fully known. Here, we summarize both preclinical and clinical data extracted from short- and long-term studies on the cardiovascular effects of e-cigarette use. Current findings support that e-cigarettes are not a harm-free alternative to tobacco smoke. However, the data are primarily derived from acute studies. The impact of chronic e-cigarette exposure is essentially unstudied. To explore the uniqueness of e-cigarettes, we contemplate the cardiovascular effects of individual e-cigarette constituents. Overall, data suggest that exposure to e-cigarettes could be a potential cardiovascular health concern. Further preclinical research and randomized trials are needed to expand basic and clinical investigations before considering e-cigarettes safe alternatives to conventional cigarettes.
Identifiants
pubmed: 31696222
pii: 5613736
doi: 10.1093/cvr/cvz256
pmc: PMC8204488
doi:
Substances chimiques
Aldehydes
0
E-Cigarette Vapor
0
Flavoring Agents
0
Metals
0
Oxidants
0
Nicotine
6M3C89ZY6R
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
40-50Subventions
Organisme : NIA NIH HHS
ID : R01 AG057046
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL139348
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.
Références
Appl In Vitro Toxicol. 2017 Mar 1;3(1):28-40
pubmed: 28337465
Toxicol In Vitro. 2013 Mar;27(2):932-8
pubmed: 23318728
Tob Control. 2019 Mar;28(2):146-151
pubmed: 29853561
Atherosclerosis. 2016 Dec;255:179-185
pubmed: 27693003
J Am Coll Cardiol. 2015 Sep 22;66(12):1378-91
pubmed: 26383726
Int J Environ Res Public Health. 2013 Oct 16;10(10):5146-62
pubmed: 24135821
Platelets. 2016 Nov;27(7):694-702
pubmed: 27096416
Sci Rep. 2016 Sep 14;6:32554
pubmed: 27624556
Vasc Med. 2018 Oct;23(5):419-425
pubmed: 29985113
Annu Rev Public Health. 2018 Apr 1;39:215-235
pubmed: 29323609
Tob Control. 2016 Nov;25(Suppl 2):ii81-ii87
pubmed: 27633767
Nicotine Tob Res. 2014 Oct;16(10):1319-26
pubmed: 24832759
Chest. 2016 Sep;150(3):606-12
pubmed: 27108682
Trends Cardiovasc Med. 2016 Aug;26(6):515-23
pubmed: 27079891
JAMA. 2018 Oct 2;320(13):1379-1380
pubmed: 30285167
Sci Rep. 2014 Feb 26;4:4133
pubmed: 24569565
PLoS One. 2013;8(3):e57987
pubmed: 23526962
Toxicol Sci. 2016 Dec;154(2):332-340
pubmed: 27613717
Circulation. 2005 Dec 20;112(25):3930-6
pubmed: 16365212
J Am Heart Assoc. 2017 Aug 30;6(9):
pubmed: 28855171
Toxicol Lett. 2017 Aug 5;277:123-128
pubmed: 28658606
J Am Heart Assoc. 2017 Sep 20;6(9):
pubmed: 28931527
Environ Sci Technol. 2016 Dec 6;50(23):13080-13085
pubmed: 27934275
Drug Alcohol Depend. 2016 Jun 01;163:256-60
pubmed: 27137404
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1560-E1569
pubmed: 29378943
Int J Biol Sci. 2017 Jul 6;13(7):868-877
pubmed: 28808419
Circ Res. 2016 Jun 10;118(12):1872-5
pubmed: 27283531
Am J Physiol Regul Integr Comp Physiol. 2018 Jun 1;314(6):R834-R847
pubmed: 29384700
J Biol Chem. 2005 Oct 28;280(43):36386-96
pubmed: 16126721
ACS Omega. 2018 Jan 31;3(1):30-36
pubmed: 29399647
Nicotine Tob Res. 2008 Dec;10(12):1737-44
pubmed: 18982536
MMWR Morb Mortal Wkly Rep. 2018 Jan 19;67(2):53-59
pubmed: 29346338
Toxicol Ind Health. 2006 Apr;22(3):117-24
pubmed: 16716041
Przegl Lek. 2014;71(11):572-5
pubmed: 25799846
MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):157-164
pubmed: 30763302
Front Physiol. 2018 Jan 11;8:1130
pubmed: 29375399
Circulation. 2014 Oct 14;130(16):1418-36
pubmed: 25156991
Cochrane Database Syst Rev. 2014;(12):CD010216
pubmed: 25515689
Am J Prev Med. 2018 Oct;55(4):455-461
pubmed: 30166079
FASEB J. 2012 Dec;26(12):4778-87
pubmed: 22906950
JAMA Cardiol. 2017 Mar 1;2(3):278-284
pubmed: 28146259
Nicotine Tob Res. 2015 Feb;17(2):134-41
pubmed: 24862971
Toxicol Lett. 2012 Feb 5;208(3):293-9
pubmed: 22119171
Int J Environ Res Public Health. 2015 May 15;12(5):5215-32
pubmed: 25988311
J Am Coll Cardiol. 2016 Jun 14;67(23):2802-2803
pubmed: 27282901
BMC Cardiovasc Disord. 2014 Jun 23;14:78
pubmed: 24958250
ACS Omega. 2017 Mar 31;2(3):1207-1214
pubmed: 28393137
Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1607-1615
pubmed: 29903732
Addiction. 2016 Mar;111(3):535-44
pubmed: 26430813
Toxicol Appl Pharmacol. 2010 Oct 15;248(2):100-10
pubmed: 20678513
Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1175-1191
pubmed: 28642230
Eur J Prev Cardiol. 2019 Jul;26(11):1219-1228
pubmed: 30823865
Heart. 2011 Nov;97(21):1776-81
pubmed: 21807659
Environ Pollut. 2014 Jan;184:523-9
pubmed: 24172659
Intern Emerg Med. 2016 Feb;11(1):85-94
pubmed: 26749533
Int J Mol Sci. 2014 Jun 25;15(7):11324-49
pubmed: 24968272
Regul Toxicol Pharmacol. 2017 Jul;87:36-53
pubmed: 28476553
Eur J Prev Cardiol. 2012 Jun;19(3):297-305
pubmed: 22779085
J Appl Physiol (1985). 2018 Mar 1;124(3):573-582
pubmed: 29097631
Int J Environ Res Public Health. 2014 Oct 28;11(11):11192-200
pubmed: 25353061
JACC Cardiovasc Imaging. 2009 Sep;2(9):1093-9
pubmed: 19761988
FASEB J. 2005 Jul;19(9):1096-107
pubmed: 15985533
Front Physiol. 2018 Jul 09;9:853
pubmed: 30038580
J Am Heart Assoc. 2018 Jul 18;7(15):
pubmed: 30021806
MMWR Morb Mortal Wkly Rep. 2016 Apr 15;65(14):361-7
pubmed: 27077789
Inhal Toxicol. 2013 May;25(6):354-61
pubmed: 23742112
Toxicology. 2008 Jan 14;243(1-2):164-76
pubmed: 18023956
NCHS Data Brief. 2017 Dec;(293):1-8
pubmed: 29319473
Sci Rep. 2018 Jul 10;8(1):10378
pubmed: 29991814
PLoS One. 2015 May 15;10(5):e0126259
pubmed: 25978043
Cardiovasc Toxicol. 2013 Dec;13(4):364-9
pubmed: 23959951
Circulation. 2000 Sep 12;102(11):1239-44
pubmed: 10982537
Am J Physiol Lung Cell Mol Physiol. 2015 Jul 15;309(2):L175-87
pubmed: 25979079
Physiol Rep. 2017 Sep;5(17):
pubmed: 28899908
Nat Rev Cardiol. 2017 Aug;14(8):447-456
pubmed: 28332500
PLoS One. 2013 Sep 11;8(9):e74974
pubmed: 24040369
PLoS One. 2017 Jan 11;12(1):e0169811
pubmed: 28076380
Int J Hyg Environ Health. 2014 Jul;217(6):628-37
pubmed: 24373737
Regul Toxicol Pharmacol. 2015 Feb;71(1):24-34
pubmed: 25460033
Am J Physiol Lung Cell Mol Physiol. 2017 Aug 1;313(2):L278-L292
pubmed: 28495856
Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3673-84
pubmed: 17921335
Mol Biol Rep. 2014 Dec;41(12):7923-8
pubmed: 25179225
Basic Clin Pharmacol Toxicol. 2009 Oct;105(4):271-80
pubmed: 19558560
Int J Environ Res Public Health. 2017 Oct 23;14(10):
pubmed: 29065549
Sci Rep. 2017 Dec 5;7(1):16974
pubmed: 29209071
PLoS One. 2016 Jun 28;11(6):e0157337
pubmed: 27351725
Curr Opin Physiol. 2018 Feb;1:198-205
pubmed: 29552675
Tob Control. 2014 Jul;23 Suppl 3:iii3-9
pubmed: 24935895